-
Company Profile
Parexel International Corp – Company Profile
Parexel International Corp (Parexel), a subsidiary of Pamplona Capital Management LLP is a biopharmaceutical outsourcing service company. It provides services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers an array of services including clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, regulatory and product development, and commercialization consulting...
Add to Basket -
Thematic Analysis
Clinical Trials Sector Scorecard, Q2 2022 Update – Thematic Research
In Q2 2022, there was increased activity in the virtual care space. Compared to Q1 2022, Novo Nordisk initiated more trials with virtual components and posted more jobs related to virtual care. Daiichi Sankyo and Takeda are planning a study in Japan that will look at the feasibility of using a wearable device to track lifestyle habits. Sanofi announced several social initiatives, including the successful pricing of its first bond linked to improving access to essential medicine, the launch of...
-
Thematic Analysis
Pharmaceutical Drug Development Sector Scorecard, Q2 2022 Update – Thematic Research
The genomics landscape was active in Q2 2022, with scores increasing for several companies. This includes Merck & Co, whose score increased to 4 due to an increase in forecasted sales for several Phase II candidates, including its oncolytic vaccine Cavatak (gebasaxturev), an mRNA vaccine, and its recombinant vector vaccine V-184 for Chikungunya fever. In Regenerative Medicine, AstraZeneca saw an increase in its score due to forecasted global sales for its oligonucleotide AZD-8601 and an increase in posted jobs in...
-
Sector Analysis
Japan Anesthesia and Respiratory Devices Market Outlook to 2025 – Anesthesia Devices, Airway Management, Respiratory Devices and Diagnostic and Measurement Devices.
“What is covered in the report about the “Japan Anesthesia and Respiratory Devices Market”? GlobalData’s “Japan Anesthesia and Respiratory Devices Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the Japan Anesthesia and Respiratory Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Airway Management, Anesthesia Devices, Diagnostic and Measurement Devices and Respiratory Devices. The Japan Anesthesia and Respiratory Devices Market report provides key information...
-
Product Insights
Muscle Wasting Disorders Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Muscle Wasting Disorders Global Clinical Trials Review, H1, 2018" provides an overview of Muscle Wasting Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on Muscle Wasting Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Mild Cognitive Impairment Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Mild Cognitive Impairment Global Clinical Trials Review, H2, 2017" provides an overview of Mild Cognitive Impairment clinical trials scenario. This report provides top line data relating to the clinical trials on Mild Cognitive Impairment. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Nocturia Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Nocturia Global Clinical Trials Review, H2, 2017" provides an overview of Nocturia clinical trials scenario. This report provides top line data relating to the clinical trials on Nocturia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Lower Limb Muscle Spasticity Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Lower Limb Muscle Spasticity Global Clinical Trials Review, H2, 2017" provides an overview of Lower Limb Muscle Spasticity clinical trials scenario. This report provides top line data relating to the clinical trials on Lower Limb Muscle Spasticity. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Lumbar Hernia/Bleichner’s Hernia Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Lumbar Hernia/Bleichner's Hernia Global Clinical Trials Review, H2, 2017" provides an overview of Lumbar Hernia/Bleichner's Hernia clinical trials scenario. This report provides top line data relating to the clinical trials on Lumbar Hernia/Bleichner's Hernia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Juvenile Rheumatoid Arthritis Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Juvenile Rheumatoid Arthritis Global Clinical Trials Review, H2, 2017" provides an overview of Juvenile Rheumatoid Arthritis clinical trials scenario. This report provides top line data relating to the clinical trials on Juvenile Rheumatoid Arthritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...